Skip to content

Pulse Corticosteroid Therapy and Effect on Brain Water Diffusivity

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00527176
Enrollment
Unknown
Registered
2007-09-10
Start date
2007-09-30
Completion date
2007-09-30
Last updated
2007-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Lupus Erythematosus

Keywords

Systemic Lupus Erythematosus, Corticosteroid, Pulse therapy, Diffusion weighted imaging, q Space Imaging

Brief summary

In daily clinical use, pulse high dosis corticosteroids are used to treat cerebral edema in different pathological situations ( surgery, trauma, tumors...). Dehydration can theorically concern extra-cellular or intracellular water, or both. The relative proportion of those two components are not known, as well their kinetics. Diffusion Weighted Imaging ( DWI) is a none invasive and none toxic technique to study those phenomena.We can also study the diffusivity anisotropy not using a Gaussian distribution but rather a non- gaussian one, more close to the reality ( q Space Imaging ). Finally, we can study the compartment redistribution between slow and rapid water molecules diffusion by bi-exponential decomposition of the diffusion signal, corresponding, theorically, respectively to the intra- and extra-cellular component. Hypothesis : The high dosis steroid pulse therapy modifies or not the water free diffusion in DWI and qSI ? Is there a modification in the diffusivity of both rapid and slow component ?

Interventions

None listed

Sponsors

Fonds National de la Recherche Scientifique
CollaboratorOTHER
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Systemic Lupus Erythematosus * normal neurological exam * informed consent * 18 yo or more

Exclusion criteria

* abnormal neurological exam * younger than 18 years old

Countries

Belgium

Contacts

Primary ContactThierry Duprez, MD
duprez@rdgn.ucl.ac.be+ 32 2 764 29 19
Backup ContactDenis J Rommel, MD
denis.rommel@clin.ucl.ac.be

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026